CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1474-1483

  Ju, Ji Hyun ^a   Jang, Kibeom ^a   Lee, Kyung Min ^a   Kim, Minsoon ^a   Kim, Jongbin ^b   Yi, Jae Youn ^c   Noh, Dong Young ^b   Shin, Incheol ^a  

^a Hanyang University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CESIUM 137; DIMETHYL SULFOXIDE; DNA; DOXORUBICIN; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RETROVIRUS VECTOR; SHORT HAIRPIN RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PLASMID; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INFECTION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD24; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DOXORUBICIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLOW CYTOMETRY; HUMANS; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NF-KAPPA B; RADIATION, IONIZING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 80053153630     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr173     Document Type: Article

References (51)

1. Pirruccello,S.J. et al. (1986) The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J. Immunol., 136, 3779-3784.
2. Aigner,S. et al. (1995) Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int. Immunol., 7, 1557-1565.
3. Daniel,L. et al. (2000) Adult mesoblastic nephroma. Pathol. Res. Pract., 196, 135-139.
4. Kristiansen,G. et al. (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am. J. Pathol., 161, 1215-1221.
5. Jacob,J. et al. (2004) Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology, 4, 454-460.
6. Kristiansen,G. et al. (2003) CD24 expression is a new prognostic marker in breast cancer. Clin. Cancer Res., 9, 4906-4913.
7. Fogel,M. et al. (1999) CD24 is a marker for human breast carcinoma. Cancer Lett., 143, 87-94.
8. Al-Hajj,M. et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA., 100, 3983-3988.
9. Ghosh,S. et al. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
10. Karin,M. et al. (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol., 18, 621-663.
11. Guttridge,D.C. et al. (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol., 19, 5785-5799.
12. Beg,A.A. et al. (1996) An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science, 274, 782-784.
13. Wang,C.Y. et al. (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784-787.
14. Wang,C.Y. et al. (1999) Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat. Med., 5, 412-417.
15. Jung,M. et al. (2001) NF-kappa B signaling pathway as a target for human tumor radiosensitization. Semin. Radiat. Oncol., 11, 346-351.
16. Karin,M. et al. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol., 3, 221-227.
17. Muller,I. et al. (2003) Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis. Cancer Res., 63, 1772-1775.
18. Li,L. et al. (2001) Cellular responses to ionizing radiation damage. Int. J. Radiat. Oncol. Biol. Phys., 49, 1157-1162.
19. Sheridan,C. et al. (2006) CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res., 8, R59.
20. Graham,F.L. et al. (1973) Transformation of rat cells by DNA of human adenovirus 5. Virology, 54, 536-539.
21. Graham,F.L. et al. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52, 456-467.
22. Runz,S. et al. (2008) CD24 induces localization of beta1 integrin to lipid raft domains. Biochem. Biophys. Res. Commun., 365, 35-41.
23. Lo,H.W. et al. (2009) A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion. Cancer Res., 69, 6790-6798.
24. Junttila,M.R. et al. (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J., 22, 954-965.
25. Tanoue,T. et al. (2002) Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol. Ther., 93, 193-202.
26. Hunter,T. et al. (1994) Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
27. Toyoshima,H. et al. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
28. Smits,V.A. et al. (2001) Checking out the G(2)/M transition. Biochim. Biophys. Acta., 1519, 1-12.
29. Yan,Y. et al. (2007) Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene, 26, 4689-4698.
30. Sethi,G. et al. (2007) Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha. Oncogene, 26, 7324-7332.
31. Jackson,D. et al. (1992) CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res., 52, 5264-5270.
32. She,Q.B. et al. (2008) Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. PLoS One, 3, e3065.
33. Brunet,A. et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868.
34. Seger,R. et al. (1995) The MAPK signaling cascade. FASEB J., 9, 726-735.
35. Dalby,K.N. et al. (1998) Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem., 273, 1496-1505.
36. Janknecht,R. et al. (1993) Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J., 12, 5097-5104.
37. Lenferink,A.E. et al. (2001) ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Cancer Res., 61, 6583-6591.
38. Donovan,J.C. et al. (2001) Constitutive MEK/MAPK activation leads to p27(Kip1) deregulation and antiestrogen resistance in human breast cancer cells. J. Biol. Chem., 276, 40888-40895.
39. Baumann,P. et al. (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res., 65, 10783-10793.
40. Fornari,F.A. et al. (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol. Pharmacol., 45, 649-656.
41. Madhusoodhanan,R. et al. (2009) NFkappaB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol. Ther., 8, 765-773.
42. Karin,M. et al. (2002) NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310.
43. Perkins,N.D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol., 8, 49-62.
44. Cafferata,E.G. et al. (2001) NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta. J. Biol. Chem., 276, 15441-15444.
45. Tergaonkar,V. et al. (2002) p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell, 1, 493-503.
46. Arlt,A. et al. (2001) Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene, 20, 859-868.
47. Ashikawa,K. et al. (2004) Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem. Pharmacol., 67, 353-364.
48. Bian,X. et al. (2001) NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem., 276, 48921-48929.
49. Bohuslav,J. et al. (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem., 279, 26115-26125.
50. Hui,L. et al. (2006) Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene, 25, 7305-7310.
51. Malinin,N.L. et al. (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature, 385, 540-544.